Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02764541
Title Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

Her2-receptor negative breast cancer

Therapies

Palbociclib

Palbociclib + Tamoxifen

Letrozole

Tamoxifen

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST